Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer

BACKGROUND: Although docetaxel-based chemohormonal therapy (CHT) is one of the standard treatments for castration-resistant prostate cancer (CRPC), pertinent biomarkers and precise mechanisms involved in the resistance for CHT for CRPC remain unknown. We investigated the relationship between chemoho...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Matsuda, Yoshinori, Narita, Shintaro, Nara, Taketoshi, Mingguo, Huang, Sato, Hiromi, Koizumi, Atsushi, Kanda, Sohei, Numakura, Kazuyuki, Saito, Mitsuru, Inoue, Takamitsu, Hiroshima, Yuko, Nanjo, Hiroshi, Satoh, Shigeru, Tsuchiya, Norihiko, Habuchi, Tomonori
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7333261/
https://ncbi.nlm.nih.gov/pubmed/32293349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-06844-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados